Clinical Trial Update: A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract [Phase 3]

View source ↗

Summary

Phase 3 trial of atezolizumab in locally advanced or metastatic urothelial or non-urothelial carcinoma of the urinary tract has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Cancer
• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Urinary Tract Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-04-04